As uncertainty about the economic impact of COVID-19 persists, the disruption is taking a toll on business supply chains and operations. What is the impact to the life sciences industry? Join us for an interactive discussion of tax and trade implications including the following:
- The implications of fluctuating production capacity and constrained resources
- Federal and international tax issues related to process and innovation R&D, changing asset value, inventory, increased capital needs, and potential losses
- Latest trade & customs landscape in the US as would affect Life Sciences, and potential developments on the horizon
Contact Walter Jaremczuk, U.S. International Corridors CMO, KPMG LLP (email@example.com) with any questions.